Coronary artery disease in outpatients with nonvalvular atrial fibrillation: results from the multicenter RAMSES study

Dogan V., Basaran O., Beton O., Tekinalp M., Bolat I., Kalaycioglu E., ...Daha Fazla

CORONARY ARTERY DISEASE, cilt.27, sa.6, ss.497-503, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 27 Sayı: 6
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1097/mca.0000000000000389
  • Dergi Adı: CORONARY ARTERY DISEASE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.497-503
  • Anahtar Kelimeler: anticoagulant therapy, coronary artery disease, nonvalvular atrial fibrillation, RHYTHM MANAGEMENT, THERAPY, RISK, ANTICOAGULATION, INTERVENTION, PREVALENCE, MORTALITY, REGISTRY, ASPIRIN, STROKE
  • Eskişehir Osmangazi Üniversitesi Adresli: Hayır

Özet

Background Nonvalvular atrial fibrillation (NVAF) frequently coexists with coronary artery disease (CAD). However, the optimal antithrombotic strategy for patients with concomitant CAD and NVAF is controversial. The aim of this study is to assess the prevalence of CAD with NVAF and to determine antithrombotic treatment options in patients with or without a history of CAD.